TOP CORPORATE NEWS : 19, May 2017

Corporate News

Top Headlines of the Day :

Pidilite Q4 Net Profit at Rs157.2 Cr
SBI Q4 Net Profit at Rs2,814 Cr
Tata Coffee YoY Cons Net Profit at Rs59.8 Cr Vs Rs27.9 Cr
Lupin gets USFDA approval for Quetiapine Fumarate Tablets
MRPL plans to expand refining capacity by 10mmt to 25mmt

SBI Q4 Net Profit at Rs2,814 Cr
SBI Q4 Net Profit at Rs2, 814 Cr
SBI Has Invoked S4A/SDR in 10 Accounts worth Rs 5,169.5 Cr as On March 31;
Slippages at Rs 9,755 Cr Vs Rs 10,357 Cr (QoQ)
Gross NPA Up 3.7% at Rs 1.12 Lk Cr Vs Rs 1.08 Lk Cr (QoQ);
Net NPA (GD) 5.1% at Rs 58,277 Cr Vs Rs 61,430 Cr (QoQ)
Gross NPA At 6.90% Vs 7.23% & Net NPA At 3.71% Vs 4.24% (QoQ)
Provisions at Rs 11,740 Cr Vs Rs 8,942.8 Cr (QoQ).

Tata Coffee YoY Cons Net Profit at Rs59.8 Cr Vs Rs27.9 Cr
Tata Coffee YoY Cons Net Profit at Rs59.8 Cr Vs Rs27.9 Cr
Revenue Up 0.2% At Rs 394.9 Cr Vs Rs 394.3 Cr
Cons EBITDA Up 44.6% At Rs 107 Cr Vs Rs 74 Cr
EBITDA Margin At 27.1% Vs 18.8%.

Pidilite Q4 Net Profit at Rs157.2 Cr
Pidilite Q4 Net Profit at Rs157.2 Cr
Revenue at Rs 1,404.3 Cr
EBITDA at Rs 257.8 Cr
EBITDA Margin At 19.9%
Pidilite Says Content with Progress In Industrial Business
Not Worried About Increasing Competition
Aim Is To Attain Historic Growth Rates Of Over 15%,

Lupin gets USFDA approval for Quetiapine Fumarate Tablets
Lupin gets USFDA approval for its Quetiapine Fumarate Extended-Release Tablets (gSeroquel XR) used to treat schizophrenia; acute manic or mixed
episodes in bipolar I disorder.
The drug had US sales of $1.27 billion (IMS MAT March 2017).

MRPL plans to expand refining capacity by 10mmt to 25mmt
Managalore Refinery and Petrochemicals Ltd (MRPL) as per media reports plans to expand refining capacity by 10mmt to 25mmt at capex of Rs15000-18000
crore.
Engineers India Limited is working on the feasibility report for refining capacity expansion and final decision on investment is likely to be taken
by Dec-2017/Jan-201– long term positive for MRPL.

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide 2 days free trial to our client.Join our services and trade with us.

GET MORE DETAILS HERE:-

Commodity Market Tips
Equity Tips
Nifty Future Tips

 

  * INVESTMENT & TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISKS, PAST PERFORMANCE IS NOT A GUARANTEE OF FUTURE PERFORMANCE.
* CAPITALSTARS INVESTMENT ADVISER: SEBI REGISTRATION NUMBER: INA000001647
Advertisements